C3658219||influenza A virus (H7N9)
C0243095||anti-neuraminidase
C0003250||monoclonal antibody
C0199176||prophylactic and therapeutic activity
C1515655||in vivo
C0043528||Zoonotic
C3658219||A(H7N9) avian influenza viruses
C0008115||China
C0086418||human
C0699943||public health
C0439663||infected
C0237401||individuals
C0683525||Treatment options
C0439663||infected
C3658219||A(H7N9)
C1443650||neuraminidase (NA) inhibitors
C0029341||influenza viruses
C3658219||A(H7N9)
C0013227||drugs
C0003250||monoclonal antibodies
C0029341||influenza virus
C3714514||infection
C0026809||murine
C0003250||monoclonal antibody
C3849272||3c10-3
C3658219||A(H7N9)
C3849272||3c10-3
C1883559||wild-type
C0029347||A/Anhui/1/2013
C3658219||H7N9
C3714514||infection
C0087111||treatment
C3849272||3c10-3
C3658219||A(H7N9)
C0026809||mice
C3849272||3c10-3
C0242831||Epitope mapping
C3849272||3c10-3
C1167622||binds
C0014442||enzyme
C3849272||3c10-3
C0243102||enzyme activity
C0042776||virus
C0007635||cultured cells
C0936012||analysis
C3849272||3c10-3
C1167622||binds
C0034861||recombinant
C1883559||wild-type
C0029347||A/Anhui/1/2013
C0026882||mutation
C1443650||NAI
C3849272||3c10-3
C3658219||A(H7N9)
C3714514||infections
C0003451||antiviral inhibitors